1. Home
  2. EVER vs OCGN Comparison

EVER vs OCGN Comparison

Compare EVER & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EverQuote Inc.

EVER

EverQuote Inc.

HOLD

Current Price

$17.67

Market Cap

571.6M

Sector

Technology

ML Signal

HOLD

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$1.31

Market Cap

492.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVER
OCGN
Founded
2008
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
571.6M
492.5M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
EVER
OCGN
Price
$17.67
$1.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$27.00
$9.75
AVG Volume (30 Days)
770.5K
6.4M
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
198.86
31.58
EPS
0.51
N/A
Revenue
$163,349,000.00
N/A
Revenue This Year
$14.73
N/A
Revenue Next Year
$11.51
$1,718.38
P/E Ratio
$35.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.88
$0.90
52 Week High
$28.73
$2.73

Technical Indicators

Market Signals
Indicator
EVER
OCGN
Relative Strength Index (RSI) 46.10 35.15
Support Level $17.25 $1.30
Resistance Level $26.33 $1.92
Average True Range (ATR) 1.06 0.06
MACD -0.14 0.01
Stochastic Oscillator 11.99 17.50

Price Performance

Historical Comparison
EVER
OCGN

About EVER EverQuote Inc.

EverQuote Inc operates an online marketplace for insurance shopping, connecting consumers with insurance providers, including carriers and agents. Its marketplace is powered by proprietary data and technology platform that delivers high-intent, pre-validated consumer referrals aligned with insurers underwriting and profitability requirements. The platform provides transparency and campaign management tools, enabling providers to evaluate marketing spend performance and manage return on investment. Consumers can visit insurance provider websites, engage by phone, or submit data to receive quotes. Services are free for consumers, and the company derives revenue principally from consumer inquiries sold as referrals to insurance providers. It derives a majority of revenue from Direct channels.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: